ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Braun Named Executive Director Of ASCO Foundation

November 17, 2006

Dana-Farber Accepts Responsibility For Death Of One Patient, Harm To Another

March 31, 1995

Winship to Open Glenn Family Breast Center

February 7, 2013

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009